Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1984 1
1987 1
1989 1
1990 4
1991 3
1992 5
1993 5
1994 8
1995 9
1996 7
1997 9
1998 8
1999 1
2000 2
2001 7
2002 8
2003 20
2004 26
2005 21
2006 25
2007 32
2008 25
2009 40
2010 53
2011 43
2012 34
2013 33
2014 34
2015 40
2016 44
2017 47
2018 32
2019 33
2020 61
2021 42
2022 55
2023 71
2024 74
2025 54

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

940 results

Results by year

Filters applied: . Clear all
Page 1
Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia (CONVERT): Initial Results of a Phase III Trial.
Mei WJ, Wang XZ, Li YF, Sun YM, Yang CK, Lin JZ, Wu ZG, Zhang R, Wang W, Li Y, Zhuang YZ, Lei J, Wan XB, Ren YK, Cheng Y, Li WL, Wang ZQ, Xu DB, Mo XW, Ju HX, Ye SW, Zhao JL, Zhang H, Gao YH, Zeng ZF, Xiao WW, Zhang XP, Zhang X, Xie E, Feng YF, Tang JH, Wu XJ, Chen G, Li LR, Lu ZH, Wan DS, Bei JX, Pan ZZ, Ding PR. Mei WJ, et al. Among authors: lu zh. Ann Surg. 2023 Apr 1;277(4):557-564. doi: 10.1097/SLA.0000000000005780. Epub 2022 Dec 20. Ann Surg. 2023. PMID: 36538627 Free PMC article. Clinical Trial.
Effect of neoadjuvant chemoradiotherapy with or without PD-1 antibody sintilimab in pMMR locally advanced rectal cancer: A randomized clinical trial.
Xiao WW, Chen G, Gao YH, Lin JZ, Wu XJ, Luo HL, Lu ZH, Wang QX, Sun R, Cai PQ, Zhu CM, Liu M, Li JB, Wang YR, Jin Y, Wang F, Luo HT, Li CL, Pan ZZ, Xu RH. Xiao WW, et al. Among authors: lu zh. Cancer Cell. 2024 Sep 9;42(9):1570-1581.e4. doi: 10.1016/j.ccell.2024.07.004. Epub 2024 Aug 1. Cancer Cell. 2024. PMID: 39094560 Free article. Clinical Trial.
Chinese Guideline for the Diagnosis and Management of Drug-Induced Liver Injury in Primary Care (2024).
Mao YM, Tang JT, Lu ZH, Shao M, Zhao WF, Zhan J, Huang ZX, Niu QH, Chen L, Chen ZF, Guo CH, Jia ZH, Li H, Liu B, Miao J, Peng ZT, Pu YL, Qu LH, Shen XM, Sun W, Wang HW, Lu XL, Xue JJ, Yang YY, Yang Z, Yang ZH, Zhang QG, Niu T, Zhu WD, Liu XL, Zhong W, Dong YN, Zhi Y, Li XY; Technology Committee on DILI Prevention, Management, Chinese Medical Biotechnology Association; Committee on Drug Liver Safety, China Primary Health Care Foundation; Study Group on Drug Induced Liver Disease, Chinese Society of Hepatology, Chinese Medical Association. Mao YM, et al. Among authors: lu zh. J Dig Dis. 2025 Jan-Feb;26(1-2):2-21. doi: 10.1111/1751-2980.13337. Epub 2025 Apr 8. J Dig Dis. 2025. PMID: 40198161
Epidemiological features and temporal trends of the co-infection between HIV and tuberculosis, 1990-2021: findings from the Global Burden of Disease Study 2021.
Zhang SX, Wang JC, Yang J, Lv S, Duan L, Lu Y, Tian LG, Chen MX, Liu Q, Wei FN, Feng XY, Yang GB, Li YJ, Wang Y, Hu XJ, Yang M, Lu ZH, Zhang SY, Li SZ, Zheng JX. Zhang SX, et al. Among authors: lu zh. Infect Dis Poverty. 2024 Aug 16;13(1):59. doi: 10.1186/s40249-024-01230-3. Infect Dis Poverty. 2024. PMID: 39152514 Free PMC article.
Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trial.
Wang DS, Ren C, Li SS, Fong WP, Wu XJ, Xiao J, Li BK, Zheng Y, Ding PR, Chen G, Qiu MZ, Wang ZQ, Wang FH, Luo HY, Wang F, Wang XZ, Wang LY, Xie DJ, Chen T, Li LR, Lu ZH, Zhai XH, Liu TS, Yuan Y, Chen JQ, Tan Q, Pan ZZ, Wan DS, Zhang R, Yuan YF, Xu RH, Li YH. Wang DS, et al. Among authors: lu zh. PLoS Med. 2024 May 10;21(5):e1004389. doi: 10.1371/journal.pmed.1004389. eCollection 2024 May. PLoS Med. 2024. PMID: 38728364 Free PMC article. Clinical Trial.
Novel cellular therapies for hepatobiliary malignancies.
Xue JN, Wang YY, Wang YC, Zhang N, Zhang LH, Lu ZH, Zhao LJ, Zhao HT. Xue JN, et al. Among authors: lu zh. Hepatobiliary Pancreat Dis Int. 2022 Oct;21(5):450-454. doi: 10.1016/j.hbpd.2022.08.014. Epub 2022 Sep 6. Hepatobiliary Pancreat Dis Int. 2022. PMID: 36100543 Review.
Self-assembled monolayer-based blue perovskite LEDs.
Wang YK, Jia F, Li X, Teale S, Xia P, Liu Y, Chan PT, Wan H, Hassan Y, Imran M, Chen H, Grater L, Sun LD, Walker GC, Hoogland S, Lu ZH, Yan CH, Liao LS, Sargent EH. Wang YK, et al. Among authors: lu zh. Sci Adv. 2023 Sep 8;9(36):eadh2140. doi: 10.1126/sciadv.adh2140. Epub 2023 Sep 8. Sci Adv. 2023. PMID: 37683007 Free PMC article.
940 results